yuzhu wang | healthcare | Best Researcher Award

Ms. yuzhu wang | healthcare | Best Researcher Award

Zhongshan hospital Fudan university | China

PUBLICATION PROFILE

Orcid

INTRODUCTION 🌟

YUZHU WANG is an accomplished clinical pharmacist currently working at Zhongshan Hospital Affiliated with Fudan University in China. With a master’s degree from Shanghai Jiao Tong University, she has established herself as a prominent figure in clinical pharmacy. Serving as the Pharmacist-in-charge, she plays an integral role in advancing the practice of pharmacy within a prestigious medical institution.

EARLY ACADEMIC PURSUITS 📚

Yuzhu Wang’s academic journey began with her graduation from Shanghai Jiao Tong University in 2015, where she earned her master’s degree. Her years of study laid the foundation for a successful career in clinical pharmacy, where she excelled academically, gaining profound knowledge in the pharmaceutical sciences.

PROFESSIONAL ENDEAVORS 💼

After completing her academic studies, Yuzhu Wang embarked on her professional career at Zhongshan Hospital Affiliated with Fudan University. As a Clinical Pharmacist, she holds the title of Pharmacist-in-charge, overseeing the clinical pharmacy services within the hospital. Her work includes collaborating with medical teams to optimize medication therapy and improve patient care.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Yuzhu Wang’s work in clinical pharmacy extends beyond everyday practice into innovative research and contributions to the field. Her focus is on improving clinical medication management and enhancing patient safety. She is actively involved in evaluating the effectiveness and safety of pharmaceutical treatments, contributing valuable insights to the healthcare system.

IMPACT AND INFLUENCE 🌍

As a respected pharmacist, Yuzhu Wang has had a lasting impact on the healthcare community. Her work influences clinical practices, making significant strides in patient care and medication safety. Through her commitment to the field of clinical pharmacy, she inspires others in her profession and contributes to the broader healthcare landscape.

ACADEMIC CITATIONS AND PUBLICATIONS 📝

Throughout her career, Yuzhu Wang has contributed to numerous academic publications, establishing her as a credible voice in clinical pharmacy research. Her works have been cited in various scientific journals and have provided invaluable knowledge to the academic and professional communities.

HONORS & AWARDS 🏆

Yuzhu Wang has received recognition for her outstanding contributions to clinical pharmacy. She has been awarded various honors and accolades for her dedication to improving patient care and advancing the profession. These honors serve as a testament to her exceptional skills, commitment, and impact in the healthcare field.

LEGACY AND FUTURE CONTRIBUTIONS 🌱

Yuzhu Wang’s legacy lies in her ongoing work to revolutionize clinical pharmacy practices. As a leading pharmacist, she continues to push boundaries and inspire innovation in patient care. Her future contributions hold the promise of further transforming the field, benefiting not only her patients but also future generations of pharmacists.

FINAL NOTE 📝

Yuzhu Wang stands as an influential figure in the field of clinical pharmacy. Her combination of academic excellence, professional dedication, research contributions, and ongoing efforts to improve healthcare outcomes make her an inspiring model of success. With a bright future ahead, her work will undoubtedly continue to leave an indelible mark on the world of pharmacy and patient care.

 TOP NOTES PUBLICATIONS 📚

Risk Factors for Postoperative Nausea and Vomiting After TACE: A Prospective Cohort Study
  • Authors: WANG Yuzhu, Xin Zhou, Guoping Li, Qianzhou Lv, Xiaoyu Li, Zhiping Yan
  • Journal: Current Oncology
  • Year: 2024
  • DOI: 10.3390/curroncol32010017

Jianfei Sun | Biosensing and Bioimaging | Best Researcher Award

Prof. Jianfei Sun | Biosensing and Bioimaging | Best Researcher Award

Southeast University | China

Publication Profile:

Google Scholar

👨‍🎓 Summary:

Prof. Jianfei Sun is a distinguished researcher and doctoral supervisor at Southeast University, China. He specializes in magnetic nanomaterials for medicine and electromagnetic therapy. As the director of the Jiangsu Key Laboratory of Biomaterials and Devices, he has pioneered methods for overcoming depth limitations in medical treatments using magnetic stimulation. With over 90 academic papers and 9 invention patents, Prof. Sun’s work has contributed significantly to both scientific advancements and technology transfer.

🎓 Education:

Prof. Sun holds a doctoral degree in a relevant field and has completed extensive research in biomaterials and electromagnetic therapies.

💼 Professional Experience:

Prof. Sun has a notable academic career at Southeast University, where he supervises doctoral students and leads cutting-edge research in biomedical engineering. His work focuses on developing advanced magnetic nanomaterials for medical applications and their integration into clinical therapies.

📚 Academic Citations:

Prof. Sun has authored over 90 papers published in renowned academic journals, including key publications in Zoological Research, ACS Applied Materials & Interfaces, and Applied Physics A. His research has been widely cited, making a significant impact in the field of medical magnetism.

🛠️ Technical Skills:

  • Magnetic Nanomaterial Synthesis

  • Electromagnetic Therapy Development

  • Precision Magnetic Stimulation

  • Biomaterial Application in Medicine

  • Patented Technology in Nanotechnology

👨‍🏫 Teaching Experience:

Prof. Sun has contributed to academia as a doctoral supervisor at Southeast University, mentoring students in the fields of biomaterials, nanotechnology, and medical engineering.

🔬 Research Interests:

His research is centered on the application of magnetic nanomaterials in medicine, particularly in electromagnetic therapies for neurological diseases. Prof. Sun’s pioneering work includes precision magnetic stimulation methods and nano-iron oxide materials used for therapeutic purposes.

📚 Top Notes Publications:

Co-seismic ruptures of the 12 May 2008, Ms 8.0 Wenchuan earthquake, Sichuan: East–west crustal shortening on oblique, parallel thrusts along the eastern edge of Tibet
    • Authors: J Liu-Zeng, Z Zhang, L Wen, P Tapponnier, J Sun, X Xing, G Hu, Q Xu, …

    • Journal: Earth and Planetary Science Letters

    • Year: 2009

Response of MAPK pathway to iron oxide nanoparticles in vitro treatment promotes osteogenic differentiation of hBMSCs
    • Authors: Q Wang, B Chen, M Cao, J Sun, H Wu, P Zhao, J Xing, Y Yang, X Zhang, …

    • Journal: Biomaterials

    • Year: 2016

Magnetic field and nano-scaffolds with stem cells to enhance bone regeneration
    • Authors: Y Xia, J Sun, L Zhao, F Zhang, XJ Liang, Y Guo, MD Weir, MA Reynolds, …

    • Journal: Biomaterials

    • Year: 2018

A novel magnetic hydrogel with aligned magnetic colloidal assemblies showing controllable enhancement of magnetothermal effect in the presence of alternating magnetic field
    • Authors: K Hu, J Sun, Z Guo, P Wang, Q Chen, M Ma, N Gu

    • Journal: Advanced Materials

    • Year: 2015

Effect of drip irrigation on strawberry growth and yield inside a plastic greenhouse
    • Authors: BZ Yuan, J Sun, S Nishiyama

    • Journal: Biosystems Engineering

    • Year: 2004

Tacrine–ferulic acid–nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl-and butyrylcholinesterase inhibitors
    • Authors: Y Chen, J Sun, L Fang, M Liu, S Peng, H Liao, J Lehmann, Y Zhang

    • Journal: Journal of Medicinal Chemistry

    • Year: 2012

Hao Gao | Healthcare Data Analysis | Best Researcher Award

Prof. Hao Gao | Healthcare Data Analysis | Best Researcher Award

Jinan University, China

Author Profiles

orcid

Scopus

Research Gate

👨‍🎓 Early Academic Pursuits

Prof. Hao Gao began his academic journey with a strong foundation in natural medicine chemistry. He received his PhD from Shenyang Pharmaceutical University in 2005, focusing on the chemistry of natural medicines. This early academic work set the stage for his future contributions to the field of Traditional Chinese Medicine (TCM). After completing his doctorate, he further honed his expertise through postdoctoral training at Tsinghua University (2006-2008), a renowned institution that significantly influenced his approach to scientific research and innovation.

💼 Professional Endeavors and Leadership

Prof. Gao’s professional trajectory has been marked by leadership roles that have shaped his career and the direction of his research. In 2008, he joined the Institute of Traditional Chinese Medicine & Natural Products at Jinan University as a faculty member. Since 2013, he has been a professor at the university and, in 2016, assumed the position of Head of the Institute of Traditional Chinese Medicine & Natural Products. In 2020, he expanded his administrative responsibilities by taking on the role of Director of the Science and Technology Department at Jinan University. Prof. Gao’s leadership has been pivotal in fostering multidisciplinary collaborations and advancing research initiatives in natural medicine chemistry.

🔬 Contributions and Research Focus

Prof. Gao’s research is primarily centered on natural medicine chemistry, with a particular focus on the active compounds and technological advancements related to Traditional Chinese Medicine (TCM). His work is dedicated to exploring under-researched medicinal materials like Lycium barbarum, Angelica sinensis, and Ophiocordyceps sinensis, which are central to TCM practices. Prof. Gao has made significant strides in identifying bioactive substances and developing novel drugs derived from TCM. Notably, his research has led to the discovery of four classes of lead compounds for anti-dementia drugs, all characterized by independent intellectual property rights.

🌍 Impact and Influence

Prof. Gao’s impact extends beyond academia, with substantial contributions to the modernization of TCM and drug development. His collaborations with international experts, such as Professor Ikuro Abe from the University of Tokyo, have facilitated the establishment of the International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, a joint initiative between China’s Ministry of Education and Jinan University. This partnership exemplifies Prof. Gao’s influence on global TCM research and highlights his role in pushing the boundaries of natural product-based drug development.

📚 Academic Citations and Recognition

Prof. Gao’s research has gained widespread recognition, reflected in his 4100 citations across various SCI journals. His work has significantly contributed to the advancement of natural medicine chemistry and TCM, making him a highly influential figure in the field. His numerous publications, with 195 journal articles and one book published, continue to shape research in TCM and pharmacology. Moreover, his leadership as an editor for the China Section of the Journal of Natural Medicines and as an editorial board member for Acta Pharmaceutica Sinica B highlights his prominence in the academic community.

🛠️ Technical Skills and Innovations

Prof. Gao’s technical expertise spans various critical areas, including the extraction, isolation, and characterization of bioactive compounds from TCM. His innovations in pharmacodynamic constituents of TCM have contributed to the discovery of novel drug candidates, some of which are in the process of patenting. With over 71 patents published or pending, Prof. Gao stands at the forefront of translating TCM practices into scientifically validated therapeutic solutions. His lab continues to focus on critical technologies that aim to enhance the efficacy and safety of TCM-derived medicines.

👩‍🏫 Teaching Experience

In addition to his research, Prof. Gao has been an integral part of the academic community at Jinan University, mentoring and guiding students in the fields of pharmacology and natural medicine chemistry. His teaching philosophy integrates cutting-edge research with practical applications in TCM, ensuring that his students are well-equipped to pursue careers in both academia and industry. As a mentor, Prof. Gao has inspired numerous graduate students and postdoctoral researchers, many of whom have gone on to make their own contributions to TCM and drug development.

🌱 Legacy and Future Contributions

Prof. Gao’s legacy is built on his pioneering work in natural medicine chemistry and the modernization of Traditional Chinese Medicine. His research continues to influence the field, with ongoing projects that promise to uncover more bioactive compounds and therapeutic agents. As his career progresses, Prof. Gao remains committed to advancing TCM through innovation and interdisciplinary collaboration. His future work will likely expand the global recognition of TCM-based drugs, pushing the boundaries of natural product drug discovery and pharmacology for the betterment of human health.

🌟 Professional Memberships and Editorial Roles

Prof. Gao is an active member of the China Association of Chinese Medicine, where he serves as Vice Chairperson of the Youth Work Committee. His role in professional societies and editorial boards, including his editorial positions in high-impact journals, underscores his authority in the fields of natural products and biosynthesis. His leadership extends to guiding the next generation of researchers and practitioners in these fields.

📖 Top Noted Publications 

Functional and structural dissection of glycosyltransferases underlying the glycodiversity of wolfberry-derived bioactive ingredients lycibarbarspermidines
    • Authors: Li, S.-Y., Wang, G.-Q., Long, L., Abe, I., Gao, H.
    • Journal: Nature Communications
    • Year: 2024
Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene
    • Authors: Dong, L., Liu, J.-Y., Wang, G.-Q., Hu, D., Gao, H.
    • Journal: Bioorganic Chemistry
    • Year: 2024
Targeted Discovery of a Natural ortho-Quinone Methide Precursor and Green Generation of Its Oligomers
    • Authors: Wang, X.-X., Deng, B.-Q., Ouyang, Z.-Q., Yao, X.-S., Gao, H.
    • Journal: Journal of Natural Products
    • Year: 2024
A Functional Switch Between Asperfumene and Fusicoccadiene Synthase and Entrance to Asperfumene Biosynthesis through a Vicinal Deprotonation-Reprotonation Process
    • Authors: Liu, J.-Y., Lin, F.-L., Taizoumbe, K.A., Gao, H., Dickschat, J.S.
    • Journal: Angewandte Chemie – International Edition
    • Year: 2024
Mechanistic characterisation of a fungal fusicoccane-type diterpene synthase involved in the biosynthesis of talaro-7,13-diene
    • Authors: Lin, F.-L., Taizoumbe, K.A., Wang, Y.-X., Gao, H., Dickschat, J.S.
    • Journal: Organic and Biomolecular Chemistry
    • Year: 2024

Wei Liang | Healthcare Data Analysis | Best Researcher Award

Dr. Wei Liang | Healthcare Data Analysis | Best Researcher Award

Doctorate at East China University of Science and Technology, China

 Author Profile 👨‍🎓

Early Academic Pursuits 🎓

Dr. Wei Liang embarked on his academic journey at East China University of Science and Technology, where he earned his Bachelor’s degree in Engineering (B.E.) in 2020. His interest in Brain-Computer Interfaces (BCI) and Machine Learning became evident during his undergraduate studies, setting the stage for his continued academic success. Currently, he is pursuing his PhD at the same institution, delving deeper into the intersection of neuroscience, computer science, and biomedical engineering. His early education laid a strong foundation for his research in the emerging field of BCI technology.

Professional Endeavors 💼

As a PhD candidate, Wei Liang is already contributing to the rapidly evolving field of Brain-Computer Interfaces, particularly in motor imagery and neural signal processing. His research involves collaboration with prominent experts in the fields of computer science, neuroscience, and biomedical engineering, such as Andrzej Cichocki, Ian Daly, and Brendan Allison. Liang’s professional journey has been shaped by these collaborations, allowing him to gain insights from diverse disciplines, further honing his expertise in BCI.

Contributions and Research Focus 🧠

Wei Liang’s research focuses on advancing Brain-Computer Interface (BCI) technology, particularly in motor imagery and neural signal processing. His work has led to the development of SecNet, a second-order neural network designed to improve motor imagery decoding from electroencephalography (EEG) signals. Liang’s innovative approaches include variance-preserving spatial patterns for EEG signal processing and the use of graph convolutional networks for optimal channel selection. These contributions have enhanced the accuracy and reliability of BCI systems, making them more applicable to real-world scenarios such as stroke rehabilitation and neural engineering.

Impact and Influence 🌍

Wei Liang’s work is making significant strides in improving BCI systems, which have far-reaching applications in medicine, rehabilitation, and human-computer interaction. By optimizing EEG decoding strategies, his research could impact the development of more effective neuroprosthetics and assistive technologies for individuals with motor impairments. His collaboration with leading researchers from around the world further amplifies the global impact of his work, positioning him as a rising star in BCI research.

Academic Citations 📚

Despite being in the early stages of his career, Wei Liang has already made a notable impact on the academic community. His research has led to the publication of five papers, accumulating a total of 14 citations and an h-index of 2. Notable papers include works published in Information Processing & Management, Frontiers in Human Neuroscience, and IEEE Journal of Biomedical and Health Informatics, among others. These publications highlight his contributions to improving BCI systems and their applications.

Technical Skills 🛠️

Wei Liang possesses a strong technical skill set, particularly in the areas of machine learning, neural network architecture, and EEG signal processing. He has expertise in developing novel algorithms for motor imagery decoding, including the use of second-order neural networks and graph convolutional networks. Liang is proficient in various computational tools and programming languages necessary for his research, positioning him as an expert in his field.

Teaching Experience 🏫

Though primarily focused on research, Wei Liang’s academic journey has also included some teaching experience, collaborating with faculty and providing guidance to students. His strong academic background, coupled with his research expertise, allows him to mentor and inspire others in the field of Brain-Computer Interfaces.

Legacy and Future Contributions 🌟

Wei Liang’s research trajectory holds great promise for shaping the future of Brain-Computer Interface technology. His innovative methodologies have the potential to revolutionize how we understand and utilize EEG signals for communication and rehabilitation. In the long term, his contributions could lead to breakthroughs in neuroprosthetics, enhancing the quality of life for individuals with disabilities. With continued dedication and innovation, Liang is on track to leave a lasting legacy in the realm of neuroscience and technology.

Teaching and Mentorship 🧑‍🏫

Although Liang is primarily focused on research, his experiences collaborating with top researchers and participating in academia have enriched his teaching and mentorship skills. His ability to translate complex ideas into understandable concepts makes him an effective communicator, ready to guide the next generation of researchers in the field of BCI.

Awards and Recognition 🏆

Wei Liang has been recognized for his groundbreaking research, publishing in high-impact journals and earning accolades for his contributions to BCI technology. As a promising young researcher, he is poised to receive even greater recognition as his work continues to influence and shape the future of the field.

Top Noted Publications📖

Novel Channel Selection Model Based on Graph Convolutional Network for Motor Imagery
    • Authors: W Liang, J Jin, I Daly, H Sun, X Wang, A Cichocki
    • Journal: Cognitive Neurodynamics
    • Year: 2023
Variance Characteristic Preserving Common Spatial Pattern for Motor Imagery BCI
    • Authors: W Liang, J Jin, R Xu, X Wang, A Cichocki
    • Journal: Frontiers in Human Neuroscience
    • Year: 2023
SecNet: A Second Order Neural Network for MI-EEG
    • Authors: W Liang, BZ Allison, R Xu, X He, X Wang, A Cichocki, J Jin
    • Journal: Information Processing & Management
    • Year: 2025
Multiscale Spatial-Temporal Feature Fusion Neural Network for Motor Imagery Brain-Computer Interfaces
    • Authors: J Jin, W Chen, R Xu, W Liang, X Wu, X He, X Wang, A Cichocki
    • Journal: IEEE Journal of Biomedical and Health Informatics
    • Year: 2024
Leveraging Transfer Superposition Theory for StableState Visual Evoked Potential Cross-Subject Frequency Recognition
    • Authors: X He, BZ Allison, K Qin, W Liang, X Wang, A Cichocki, J Jin
    • Journal: IEEE Transactions on Biomedical Engineering
    • Year: 2024

farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Åbo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

💼 Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

📖Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Fernando López | Healthcare Data Analysis | Excellence in Research

Assoc Prof Dr. Fernando López | Healthcare Data Analysis | Excellence in Research

Assoc Prof Dr. Fernando López at Hospital Clinico Universitario – Universidad de Valencia, Spain

👨‍🎓  Profile

Early Academic Pursuits 🎓

Dr. Fernando López began his academic journey at the Universidad de Cádiz, where he earned his Licenciatura in Medicine and Surgery from 1987 to 1993. His dedication led him to further his education through the Official Doctoral Program in Medicine and Surgery at the Universitat de València, culminating in a doctoral degree awarded with “Sobresaliente cum laude” in 2001.

Professional Endeavors 🏥

Dr. López completed his specialized training in General Surgery and Digestive System Surgery via the MIR program at the Hospital Clínico Universitario de Valencia from 1995 to 2000. He currently serves as an Associate Professor in the Department of Surgery at the Universitat de València, where he has been actively involved since 2011.

Contributions and Research Focus 🔍

Dr. López has made significant contributions to surgical research, particularly in the context of the COVID-19 pandemic. He is a co-author of several influential articles addressing surgical risks and outcomes during this crisis, with particular emphasis on the integration of machine learning for risk prediction. His work has been published in leading journals, reflecting his commitment to advancing surgical practices.

Impact and Influence 🌍

His research has garnered considerable attention, with publications in both national and international journals totaling 35, including articles in high-impact publications such as the British Journal of Surgery. His collaborative work with the COVIDSurg Collaborative has had a meaningful impact on surgical protocols during the pandemic.

Academic Cites 📚

Dr. López’s research has resulted in a notable cumulative impact factor of 76.697 across his indexed publications, illustrating the significant reach and influence of his work in the academic community.

Technical Skills ⚙️

As an experienced surgeon, Dr. López possesses a robust set of technical skills, particularly in advanced trauma and emergency care. He has been involved in teaching various advanced trauma life support courses and has contributed to international workshops, underscoring his proficiency and commitment to surgical education.

Teaching Experience 👨‍🏫

In addition to his clinical practice, Dr. López has extensive teaching experience, having tutored 35 residents in General Surgery and Digestive Surgery. He has organized and led numerous courses and seminars, including advanced trauma support training, reflecting his passion for educating the next generation of surgeons.

Legacy and Future Contributions 🌱

Looking ahead, Dr. López aims to continue his research in surgical safety and education, leveraging his experience and expertise to foster advancements in the field. His ongoing commitment to mentoring residents and collaborating on impactful research will undoubtedly leave a lasting legacy in the surgical community.

📖 Top Noted Publications

 

Characteristics of gastrointestinal stromal tumors associated to other tumors, 2024

Characteristics of gastrointestinal stromal tumors associated to other tumors, 2024

Glasbey, J. C., Nepogodiev, D., COVIDSurg Collaborative. (2021). Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. British Journal of Surgery, 6, pp. 1-19.

LUCENTUM Project Researchers. (2021). Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery: Prospective, multicenter, observational cohort study. International Journal of Surgery, 97, pp. 1-35.

Glasbey, J. C., Nepogodiev, D., COVIDSurg Collaborative. (2021). Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. British Journal of Surgery, 6, pp. 1-19.

Sebastian Blecha | Patientensicherheit | Women Researcher Award

Prof Dr. Sebastian Blecha | Patientensicherheit | Women Researcher Award

Prof Dr. Sebastian Blecha at Universitätsklinikum Regensburg, Germany

👨‍🎓 Profile

Summary ✨

Prof. Dr. Sebastian Blecha is an expert in anesthesiology and intensive care medicine, currently serving as an associate professor and leading a cardiac-thoracic intensive care unit.

 Education 📚

Prof. Dr. Sebastian Blecha completed his medical degree at the University of Leipzig (2003–2009) and trained as a nurse at Elbland Klinikum Riesa (1998–2001). He earned his PhD in Neurooncology in 2012 and completed his Habilitation on quality of life post-acute lung failure in 2021 at the University of Regensburg.

Professional Experience 💼

He currently holds an associate professorship in Anesthesiology (since 2024) and serves as the head of the Cardiac-Thoracic ICU at University Hospital Regensburg (2020–present). His previous roles include various positions in anesthesiology at University Hospitals in Regensburg and Leipzig (2011–2020), culminating in his qualification as a cardioanesthesiologist (2017–2019).

Research Interests 🔬

Prof. Blecha’s research focuses on intensive care medicine, particularly the quality of life of survivors after severe lung conditions and operational workflows in neurooncology.

Top Noted Publications 📖